Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jun;67(6):1242–1247. doi: 10.1038/bjc.1993.232

Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.

E J Derbyshire 1, L de Leij 1, E J Wawrzynczak 1
PMCID: PMC1968532  PMID: 8390281

Abstract

Monoclonal antibodies (Mabs) from the Second International Workshop on Small Cell Lung Cancer (SCLC) Antigens that recognise the cluster 2 SCLC-associated antigen mediated potent and selective cytotoxic effects in an indirect assay of immunotoxin cytotoxicity. In this assay, the NCI-H69 cell line was treated with each Mab at 4 degrees C, washed to remove unbound Mab, and then incubated at 37 degrees C in the presence of a fixed concentration, 1 x 10(-8) M, of the screening agent, sheep anti-mouse IgG-ricin A chain. The use of a fixed high concentration of screening agent led to a 300-fold overestimate of the potency of a cluster 2-directed immunotoxin, MOC-31-ricin A chain. In contrast, when the concentration of the screening agent was identical to the Mab concentration, a precise match to immunotoxin potency was obtained. MOC-31-ricin A chain selectivity inhibited the incorporation of [3H]leucine by the NCI-H69, SW2 and GLC-8 SCLC cell lines by 50% at a concentration between 3 x 10(-11) M and 3 x 10(-10) M, and by the NCI-H125 lung adenocarcinoma cell line at 7 x 10(-11) M, but exerted no selective toxic effects upon human lung and non-lung tumour cell lines lacking surface expression of the cluster 2 antigen.

Full text

PDF
1242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beverley P. C., Olabiran Y., Ledermann J. A., Bobrow L. G., Souhami R. L. Results of the central data analysis. Br J Cancer Suppl. 1991 Jun;14:10–19. [PMC free article] [PubMed] [Google Scholar]
  2. Carney D. N., Gazdar A. F., Bepler G., Guccion J. G., Marangos P. J., Moody T. W., Zweig M. H., Minna J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985 Jun;45(6):2913–2923. [PubMed] [Google Scholar]
  3. Derbyshire E. J., Henry R. V., Stahel R. A., Wawrzynczak E. J. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines. Br J Cancer. 1992 Sep;66(3):444–451. doi: 10.1038/bjc.1992.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Derbyshire E. J., Wawrzynczak E. J. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity. Br J Cancer Suppl. 1991 Jun;14:74–77. [PMC free article] [PubMed] [Google Scholar]
  5. Durbin H., Rodrigues N., Bodmer W. F. Further characterization, isolation and identification of the epithelial cell-surface antigen defined by monoclonal antibody AUA1. Int J Cancer. 1990 Mar 15;45(3):562–565. doi: 10.1002/ijc.2910450331. [DOI] [PubMed] [Google Scholar]
  6. Elias D. J., Hirschowitz L., Kline L. E., Kroener J. F., Dillman R. O., Walker L. E., Robb J. A., Timms R. M. Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma. Cancer Res. 1990 Jul 1;50(13):4154–4159. [PubMed] [Google Scholar]
  7. Gilliland D. G., Steplewski Z., Collier R. J., Mitchell K. F., Chang T. H., Koprowski H. Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4539–4543. doi: 10.1073/pnas.77.8.4539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Linnenbach A. J., Wojcierowski J., Wu S. A., Pyrc J. J., Ross A. H., Dietzschold B., Speicher D., Koprowski H. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci U S A. 1989 Jan;86(1):27–31. doi: 10.1073/pnas.86.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Manderino G. L. Measurement of murine IgG and IgM concentrations in the SCLC MAb panel; effects of concentration on sensitivity and specificity. Br J Cancer Suppl. 1991 Jun;14:64–66. [PMC free article] [PubMed] [Google Scholar]
  10. Perez M. S., Walker L. E. Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker. J Immunol. 1989 May 15;142(10):3662–3667. [PubMed] [Google Scholar]
  11. Postmus P. E., de Ley L., van der Veen A. Y., Mesander G., Buys C. H., Elema J. D. Two small cell lung cancer cell lines established from rigid bronchoscope biopsies. Eur J Cancer Clin Oncol. 1988 Apr;24(4):753–763. doi: 10.1016/0277-5379(88)90311-2. [DOI] [PubMed] [Google Scholar]
  12. Shen J. W., Atkinson B., Koprowski H., Sears H. F. Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody. Int J Cancer. 1984 Apr 15;33(4):465–468. doi: 10.1002/ijc.2910330408. [DOI] [PubMed] [Google Scholar]
  13. Simon B., Podolsky D. K., Moldenhauer G., Isselbacher K. J., Gattoni-Celli S., Brand S. J. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2755–2759. doi: 10.1073/pnas.87.7.2755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Souhami R. L., Beverley P. C., Bobrow L. G. Antigens of small-cell lung cancer. First International Workshop. Lancet. 1987 Aug 8;2(8554):325–326. doi: 10.1016/s0140-6736(87)90904-4. [DOI] [PubMed] [Google Scholar]
  15. Souhami R. L., Beverley P. C., Bobrow L. G., Ledermann J. A. Antigens of lung cancer: results of the second international workshop on lung cancer antigens. J Natl Cancer Inst. 1991 May 1;83(9):609–612. doi: 10.1093/jnci/83.9.609. [DOI] [PubMed] [Google Scholar]
  16. Strnad J., Hamilton A. E., Beavers L. S., Gamboa G. C., Apelgren L. D., Taber L. D., Sportsman J. R., Bumol T. F., Sharp J. D., Gadski R. A. Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res. 1989 Jan 15;49(2):314–317. [PubMed] [Google Scholar]
  17. Till M., May R. D., Uhr J. W., Thorpe P. E., Vitetta E. S. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Cancer Res. 1988 Mar 1;48(5):1119–1123. [PubMed] [Google Scholar]
  18. Wawrzynczak E. J., Derbyshire E. J., Henry R. V., Parnell G. D., Smith A., Waibel R., Stahel R. A. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer. Br J Cancer Suppl. 1991 Jun;14:71–73. [PMC free article] [PubMed] [Google Scholar]
  19. Wawrzynczak E. J., Derbyshire E. J., Henry R. V., Parnell G. D., Smith A., Waibel R., Stahel R. A. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen. Br J Cancer. 1990 Sep;62(3):410–414. doi: 10.1038/bjc.1990.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wawrzynczak E. J., Derbyshire E. J. Immunotoxins: the power and the glory. Immunol Today. 1992 Oct;13(10):381–383. doi: 10.1016/0167-5699(92)90084-K. [DOI] [PubMed] [Google Scholar]
  21. Wawrzynczak E. J. Rational design of immunotoxins: current progress and future prospects. Anticancer Drug Des. 1992 Oct;7(5):427–441. [PubMed] [Google Scholar]
  22. Wawrzynczak E. J., Zangemeister-Wittke U., Waibel R., Henry R. V., Parnell G. D., Cumber A. J., Jones M., Stahel R. A. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer. Br J Cancer. 1992 Aug;66(2):361–366. doi: 10.1038/bjc.1992.271. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES